Diagnosis of Growth Hormone Deficiency is Affected by Calibrators Used in GH Immunoassays

Abstract

Growth hormone (GH) values vary among immunoassays depending on different factors, such as the assay method used, specificity of antibodies, matrix difference between standards and samples, and interference with endogenous GH binding proteins (GHBPs). We evaluated whether the use of different calibrators for GH measurement may affect GH values and, consequently, the formulation of GH deficiency (GHD) diagnosis in children. Twenty-three short children (5 F, 18 M; age 11.4±3.1 years), with the clinical characteristics of GHD (height:  − 2.3±0.5 SDS; height velocity  − 2.3±1.5 SDS; IGF-I  − 1.2±0.9 SDS), underwent GH stimulation tests to confirm the clinical diagnosis of GHD. Serum GH values were measured with Immulite 2000, using 2 different calibrators, IS 98/574, a recombinant 22 kDa molecule of more than 95% purity, and IS 80/505, of pituitary origin and resembling a variety of GH isoforms. We found blunted GH secretion in 20 subjects with the Immulite assay using the IS 98/574 GH as a calibrator, confirming the diagnosis of GHD. Subsequently, using IS 80/505 GH as a calibrator, in the same samples only 14 children showed reduced GH levels. The total cost for the first year of GH therapy of patients diagnosed with IS 98/574 as a calibrator was higher than that for patients diagnosed with IS 80/505 as a calibrator. These data confirm that GH values may depend on different calibrators used in the GH assay, affecting the formulation of GHD diagnosis and the consequent decision to start GH treatment.

Key words

growth hormone - chemiluminescent assay - calibrator - growth hormone deficiency - children

• References

• 1 GH Research Society . Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3993
• 2 Popii V, Baumann G. Laboratory measurement of growth hormone. Clin Chim Acta 2004; 350: 1-16
• 3 Chaler EA, Rivarola MA, Guerci B, Ciaccio M, Costanzo M, Travaglino P, Maceiras M, Pagani S, Meazza C, Bozzola E, Barberi S, Belgorosky A, Bozzola M. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment. Horm Res 2006; 66: 231-235
• 4 Obara-Moszyńska M, Kedzia A, Korman E, Niedziela M. Usefulness of growth hormone (GH) stimulation tests and IGF-I concentration measurement in GH deficiency diagnosis. J Pediatr Endocrinol Metab 2008; 21: 569-579
• 5 Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassay: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 2010; 20: 19-25
• 6 Fisker S, Orskov H. Factors modifying growth hormone estimates in immunoassays. Horm Res 1996; 46: 183-187
• 7 Chaler E, Belgorosky A, Maceiras M, Mendioroz M, Rivarola MA. Between-assay differences in serum GH measurements: importance in the diagnosis of GH deficiency in childhood. Clin Chem 2001; 47: 1735-1738
• 8 Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011; 57: 555-559
• 9 Granada ML, Sanmartí A, Lucas A, Salinas I, Carrascosa A, Foz M, Audí L. Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children. Acta Paediatr Scandinav 1990; 370 (Suppl) 63-70
• 10 Markkanen H, Pekkarinen T, Välimäki MJ, Alfthan H, Kauppinen-Mäkelin R, Sane T, Stenman UH. Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls. Clin Chem 2006; 52: 468-473
• 11 Tanaka T, Tachibana K, Shimatsu A, Katsumata N, Tsushima T, Hizuka N, Fujieda K, Yokoya S, Irie M. A nationwide attempt to standardize growth hormone assays. Horm Res 2005; 64 (Suppl. 02) 6-11
• 12 Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006; 29: 581-593
• 13 Marshall WA, Tanner JM. Variation in pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23
• 14 Bristow AF, Jespersen AM. The Second International Standard for somatropin (recombinant DNA-derived human growth hormone): preparation and calibration in an international collaborative study. Biologicals 2001; 29: 97-106
• 15 Boquete HR, Sobrado PG, Fideleff HL, Sequera AM, Giaccio AV, Suárez MG, Ruibal GF, Miras M. Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. J Clin Endocrinol Metab 2003; 88: 4702-4708
• 16 Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-1298
• 17 Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, Nishi Y, Miyamoto S, Sasaki N, Kurimoto F, Stene M, Tsuchiya Y. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 1994; 131: 27-32
• 18 Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol 1996; 134: 184-189
• 19 Galluzzi F, Quaranta MR, Salti R, Saieva C, Nanni L, Seminara S. Are IGF-I and IGF-BP3 useful for diagnosing growth hormone deficiency in children of short stature?. J Pediatr Endocrinol Metab 2010; 23: 1273-1279
• 20 Carrozza C, Lapolla R, Canu G, Annunziata F, Torti E, Baroni S, Zuppi C. Human growth hormone (GH) immunoassay: standardization and clinical implications. Clin Chem Lab Med 2011; 49: 851-853
• 21 Andersson AM, Orskov H, Ranke MB, Shalet S, Skakkebaek NE. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol 1995; 132: 340-343
• 22 Wieringa GE, Barth JH, Trainer PJ. Growth hormone assay standardization: a biased view?. Clin Endocrinol (Oxf) 2004; 60: 538-539
• 23 Trainer PJ, Barth J, Sturgeon C, Wieringaon G. Consensus statement on the standardisation of GH assays. Eur J Endocrinol 2006; 155: 1-2
• 24 Sheppard MC. Growth hormone assay standardization: an important clinical advance. Clinical Endocrinology (Oxf) 2007; 66: 157-161
• 25 Wood P. Growth hormone: its measurement and the need for assay harmonization. Ann Clin Biochem 2001; 38: 471-482